BAFL 46.45 Increased By ▲ 1.65 (3.68%)
BIPL 21.00 Increased By ▲ 0.02 (0.1%)
BOP 5.87 Increased By ▲ 0.59 (11.17%)
CNERGY 4.75 Increased By ▲ 0.33 (7.47%)
DFML 15.93 Increased By ▲ 0.12 (0.76%)
DGKC 71.90 Increased By ▲ 0.59 (0.83%)
FABL 28.00 Increased By ▲ 0.20 (0.72%)
FCCL 17.25 Decreased By ▼ -0.04 (-0.23%)
FFL 8.65 Decreased By ▼ -0.09 (-1.03%)
GGL 13.14 Decreased By ▼ -0.02 (-0.15%)
HBL 116.40 Increased By ▲ 3.00 (2.65%)
HUBC 121.25 Decreased By ▼ -0.65 (-0.53%)
HUMNL 7.88 Decreased By ▼ -0.06 (-0.76%)
KEL 3.32 Decreased By ▼ -0.05 (-1.48%)
LOTCHEM 28.00 Increased By ▲ 0.10 (0.36%)
MLCF 39.43 No Change ▼ 0.00 (0%)
OGDC 109.45 Increased By ▲ 0.18 (0.16%)
PAEL 18.30 No Change ▼ 0.00 (0%)
PIBTL 5.77 Increased By ▲ 0.03 (0.52%)
PIOC 111.25 Increased By ▲ 1.25 (1.14%)
PPL 93.85 Increased By ▲ 0.24 (0.26%)
PRL 25.64 Increased By ▲ 0.49 (1.95%)
SILK 1.05 Decreased By ▼ -0.01 (-0.94%)
SNGP 63.55 Decreased By ▼ -0.15 (-0.24%)
SSGC 12.15 Decreased By ▼ -0.10 (-0.82%)
TELE 8.69 Decreased By ▼ -0.19 (-2.14%)
TPLP 13.75 Decreased By ▼ -0.15 (-1.08%)
TRG 86.95 Increased By ▲ 1.15 (1.34%)
UNITY 25.95 Decreased By ▼ -0.15 (-0.57%)
WTL 1.59 Decreased By ▼ -0.01 (-0.63%)
BR100 6,291 Increased By 60.4 (0.97%)
BR30 21,928 Increased By 188.6 (0.87%)
KSE100 61,289 Increased By 558.7 (0.92%)
KSE30 20,438 Increased By 198.2 (0.98%)

LAHORE: Government said on Monday it was investigating two local distributors of Swiss pharmaceutical company Roche’s Avastin cancer drug after 12 diabetic patients injected with the drug went blind.

The Drug Regulatory Authority of Pakistan (DRAP) said the health authorities in Punjab, the most populous province, had launched the investigation into local use of the drug Avastin, which is licensed for use in Pakistan.

“Incidents of loss of vision in diabetic patients have been reported following treatment with Altered/Dispen-sed/Diluted Avastin injection,” the regulator said in a statement.

Javed Akram, the province’s Minister for Specialised Health, said police were questioning two men they believe to be the drug’s distributors in the state.

“A high level committee has been constituted to probe the issue. A case has been registered against the distributor and his aide,” Akram said.

Following the incidents, the DRAP instructed the importer to recall the suspected batches of Avastin 100mg injection, which it said had been created illegally.

“The sale/distribution of registered Avastin Injection has been put on halt till verification of its quality through sampling and laboratory testing to safeguard public health,” it said in a statement on its website.

On its website, Roche said Avastin was approved in more than 130 countries, including the United States, to treat several types of cancer. Roche’s Pakistan spokesman did not answer several calls.

Avastin was used as an eye treatment off-label, meaning outside of the approved use. Cancer drug Avastin, when used at much lower doses, is similar to eye drug Lucentis, and is used in many countries as a low-cost option to treat certain blindness-causing conditions.

Alam Sher, Punjab’s deputy drug controller who filed the police complaint against the distributors, told Reuters that some companies buy Avastin and repackage it in smaller doses to make it more affordable for patients.

A sharp drop in the value of the local currency against the US dollar has inflated the price of drugs in Pakistan, many of which are either imported or based on imported ingredients. Record high inflation has also diminished the purchasing power of many people.

Comments

Comments are closed.

Incidents of loss of vision: DRAP says investigating cancer drug distributors

Nepra reserves verdict on KE’s pleas for 20-year licences

Dispute settlement mechanisms: BoI asked to show ‘flexibility’

PC takes up sale of govt properties with FA

PIA divestment: PC inks ‘FASA’ with FA

NAC lowers FY23 growth rate to -0.17pc

FBR gets data of unregistered sugar buyers

UoSC/wheeling charges: Nepra reluctant to approve ‘heavy cost’

IMF team briefed about tax policy reforms

If conviction of Musharraf upheld ‘then it must be known that it will have consequences...’: SC judge

‘Wave 24’ shows 7pc improvement: OICCI unveils promising upswing in business confidence